Oral Presentation Showcases Early Ability to Predict Responders to Trudhesa
New Analysis Suggest Patient-Reported Benefits of Long-Term Use with Trudhesa
Read more at globenewswire.comAll information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
Oral Presentation Showcases Early Ability to Predict Responders to Trudhesa
New Analysis Suggest Patient-Reported Benefits of Long-Term Use with Trudhesa
Read more at globenewswire.com| Symbol | Last | Chg | %Chg |
|---|---|---|---|
| IMPL | 0.0400 | -0.0150 | -27.27% |
| Impel Pharmaceuticals Inc | |||